A Randomized Trial of Preoperative Prophylactic Antibiotics Prior to Kidney Stone Surgery (Percutaneous Nephrolithotomy [PCNL])

NCT02384200 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2019-08-22

Study results available
· View outcomes & findings →

Summary

When patients are going to have surgery to remove large kidney stones (percutaneous nephrolithotomy \[PCNL\]), it is not clear whether the patients benefit from a course of prophylactic preoperative oral antibiotics; currently both the use of prophylactic preoperative oral antibiotics and no prophylactic oral antibiotics are considered to be within standard-of-care.

This study will randomize patients to preoperative prophylactic antibiotics or no antibiotics to determine if the use of preoperative prophylactic antibiotics decreases the postoperative risk of localized urinary tract infection (UTI) and/or systemic infection that started in the urinary tract (sepsis or urosepsis).

Conditions

Interventions

DRUG

nitrofurantoin monohydrate/macrocrystalline capsules

1 week course of preoperative nitrofurantoin monohydrate/macrocrystalline capsules 100 milligrams twice daily

DRUG

ampicillin

IV (2 g)

DRUG

gentamicin

IV (5 mg/kg)

DRUG

vancomycin

IV (1 g)

DRUG

ceftriaxone

IV (2 g)

Sponsors & Collaborators

  • Mayo Clinic

    collaborator OTHER
  • University of British Columbia

    collaborator OTHER
  • The Cleveland Clinic

    collaborator OTHER
  • Duke University

    collaborator OTHER
  • Ohio State University

    collaborator OTHER
  • Dartmouth-Hitchcock Medical Center

    collaborator OTHER
  • Vanderbilt University

    collaborator OTHER
  • New York University

    collaborator OTHER
  • University of California, San Diego

    lead OTHER

Principal Investigators

  • Roger L Sur, MD · University of California, San Diego

  • Daniel L Miller, MD MPH · University of California, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-03-31
Primary Completion
2017-02-01
Completion
2019-06-01

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02384200 on ClinicalTrials.gov